Skip Navigation
Skip to contents

JPTM : Journal of Pathology and Translational Medicine


Author index

Page Path
HOME > Articles and issues > Author index
Hyun Jung Kim 1 Article
Prognostic Impact of Fusobacterium nucleatum Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II/III Colorectal Cancers Treated with Adjuvant Chemotherapy
Hyeon Jeong Oh, Jung Ho Kim, Jeong Mo Bae, Hyun Jung Kim, Nam-Yun Cho, Gyeong Hoon Kang
J Pathol Transl Med. 2019;53(1):40-49.   Published online December 26, 2018
  • 14,408 View
  • 222 Download
  • 29 Citations
AbstractAbstract PDFSupplementary Material
This study aimed to investigate the prognostic impact of intratumoral Fusobacterium nucleatum in colorectal cancer (CRC) treated with adjuvant chemotherapy.
F. nucleatumDNA was quantitatively measured in a total of 593 CRC tissues retrospectively collectedfrom surgically resected specimens of stage III or high-risk stage II CRC patients who had receivedcurative surgery and subsequent oxaliplatin-based adjuvant chemotherapy (either FOLFOXor CAPOX). Each case was classified into one of the three categories: F. nucleatum–high, –low, or –negative.
No significant differences in survival were observed between the F.nucleatum–high and –low/negative groups in the 593 CRCs (p = .671). Subgroup analyses accordingto tumor location demonstrated that disease-free survival was significantly better in F.nucleatum–high than in –low/negative patients with non-sigmoid colon cancer (including cecal,ascending, transverse, and descending colon cancers; n = 219; log-rank p = .026). In multivariateanalysis, F. nucleatum was determined to be an independent prognostic factor in non-sigmoidcolon cancers (hazard ratio, 0.42; 95% confidence interval, 0.18 to 0.97; p = .043). Furthermore,the favorable prognostic effect of F. nucleatum–high was observed only in a non-microsatellite instability-high (non-MSI-high) subset of non-sigmoid colon cancers (log-rank p = 0.014), but not ina MSI-high subset (log-rank p = 0.844), suggesting that the combined status of tumor locationand MSI may be a critical factor for different prognostic impacts of F. nucleatum in CRCs treatedwith adjuvant chemotherapy.
Intratumoral F. nucleatum load is a potential prognosticfactor in a non-MSI-high/non-sigmoid/non-rectal cancer subset of stage II/III CRCs treatedwith oxaliplatin-based adjuvant chemotherapy.


Citations to this article as recorded by  
  • Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy
    Li Yang, Aitian Li, Ying Wang, Yi Zhang
    Signal Transduction and Targeted Therapy.2023;[Epub]     CrossRef
  • La asociación entre Fusobacterium nucleatum y el cáncer colorrectal: una revisión sistemática y metaanálisis
    Paola Villar-Ortega, Manuela Expósito-Ruiz, Miguel Gutiérrez-Soto, Miguel Ruiz-Cabello Jiménez, José María Navarro-Marí, José Gutiérrez-Fernández
    Enfermedades Infecciosas y Microbiología Clínica.2022; 40(5): 224.     CrossRef
  • The association between Fusobacterium nucleatum and cancer colorectal: A systematic review and meta-analysis
    Paola Villar-Ortega, Manuela Expósito-Ruiz, Miguel Gutiérrez-Soto, Miguel Ruiz-Cabello Jiménez, José María Navarro-Marí, José Gutiérrez-Fernández
    Enfermedades infecciosas y microbiologia clinica (English ed.).2022; 40(5): 224.     CrossRef
  • Suppression of Berberine and Probiotics (in vitro and in vivo) on the Growth of Colon Cancer With Modulation of Gut Microbiota and Butyrate Production
    Chao Huang, Ying Sun, Sheng-rong Liao, Zhao-xin Chen, Han-feng Lin, Wei-zeng Shen
    Frontiers in Microbiology.2022;[Epub]     CrossRef
  • Prognostic and clinicopathological significance of Fusobacterium nucleatum in colorectal cancer: a systemic review and meta-analysis
    Younghoon Kim, Nam Yun Cho, Gyeong Hoon Kang
    Journal of Pathology and Translational Medicine.2022; 56(3): 144.     CrossRef
  • Iron accelerates Fusobacterium nucleatum–induced CCL8 expression in macrophages and is associated with colorectal cancer progression
    Taishi Yamane, Yohei Kanamori, Hiroshi Sawayama, Hiromu Yano, Akihiro Nita, Yudai Ohta, Hironori Hinokuma, Ayato Maeda, Akiko Iwai, Takashi Matsumoto, Mayuko Shimoda, Mayumi Niimura, Shingo Usuki, Noriko Yasuda-Yoshihara, Masato Niwa, Yoshifumi Baba, Taka
    JCI Insight.2022;[Epub]     CrossRef
  • Clinicopathological differences of high Fusobacterium nucleatum levels in colorectal cancer: A review and meta-analysis
    Yi Wang, Yuting Wen, Jiayin Wang, Xin Lai, Ying Xu, Xuanping Zhang, Xiaoyan Zhu, Chenglin Ruan, Yao Huang
    Frontiers in Microbiology.2022;[Epub]     CrossRef
  • Clinical Significance of Fusobacterium nucleatum and Microsatellite Instability in Evaluating Colorectal Cancer Prognosis
    Yanxuan Xie, Xiaoyang Jiao, Mi Zeng, Zhiqiang Fan, Xin Li, Yumeng Yuan, Qiaoxin Zhang, Yong Xia
    Cancer Management and Research.2022; Volume 14: 3021.     CrossRef
  • Influence of the Microbiome Metagenomics and Epigenomics on Gastric Cancer
    Precious Mathebela, Botle Precious Damane, Thanyani Victor Mulaudzi, Zilungile Lynette Mkhize-Khwitshana, Guy Roger Gaudji, Zodwa Dlamini
    International Journal of Molecular Sciences.2022; 23(22): 13750.     CrossRef
  • Circulating IgA Antibodies Against Fusobacterium nucleatum Amyloid Adhesin FadA are a Potential Biomarker for Colorectal Neoplasia
    Jung Eun Baik, Li Li, Manish A. Shah, Daniel E. Freedberg, Zhezhen Jin, Timothy C. Wang, Yiping W. Han
    Cancer Research Communications.2022; 2(11): 1497.     CrossRef
  • Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status
    Ji Ae Lee, Seung-Yeon Yoo, Hyeon Jeong Oh, Seorin Jeong, Nam-Yun Cho, Gyeong Hoon Kang, Jung Ho Kim
    Cancer Immunology, Immunotherapy.2021; 70(1): 47.     CrossRef
  • Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study
    Yannick Eisele, Patrick M. Mallea, Biljana Gigic, W. Zac Stephens, Christy A. Warby, Kate Buhrke, Tengda Lin, Juergen Boehm, Petra Schrotz-King, Sheetal Hardikar, Lyen C. Huang, T. Bartley Pickron, Courtney L. Scaife, Richard Viskochil, Torsten Koelsch, A
    Clinical Colorectal Cancer.2021; 20(3): e165.     CrossRef
  • Role of gut microbiota in epigenetic regulation of colorectal Cancer
    Yinghui Zhao, Chuanxin Wang, Ajay Goel
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2021; 1875(1): 188490.     CrossRef
  • Fusobacterium nucleatum: caution with interpreting historical patient sample cohort
    Kate L. F. Johnstone, Sinead Toomey, Stephen Madden, Brian D. P. O’Neill, Bryan T Hennessy
    Journal of Pathology and Translational Medicine.2021; 55(6): 415.     CrossRef
  • Fusobacterium nucleatum colonization is associated with decreased survival of helicobacter pylori-positive gastric cancer patients
    Yung-Yu Hsieh, Shui-Yi Tung, Hung-Yu Pan, Te-Sheng Chang, Kuo-Liang Wei, Wei-Ming Chen, Yi-Fang Deng, Chung-Kuang Lu, Yu-Hsuan Lai, Cheng-Shyong Wu, Chin Li
    World Journal of Gastroenterology.2021; 27(42): 7311.     CrossRef
  • Analysis of changes in microbiome compositions related to the prognosis of colorectal cancer patients based on tissue-derived 16S rRNA sequences
    Sukjung Choi, Jongsuk Chung, Mi-La Cho, Donghyun Park, Sun Shim Choi
    Journal of Translational Medicine.2021;[Epub]     CrossRef
  • Gastrointestinal tumors and infectious agents: A wide field to explore
    Miriam López-Gómez, Belén García de Santiago, Pedro-David Delgado-López, Eduardo Malmierca, Jesús González-Olmedo, César Gómez-Raposo, Carmen Sandoval, Pilar Ruiz-Seco, Nora Escribano, Jorge Francisco Gómez-Cerezo, Enrique Casado
    World Journal of Meta-Analysis.2021; 9(6): 505.     CrossRef
  • Gut Microbiota Profiles in Early- and Late-Onset Colorectal Cancer: A Potential Diagnostic Biomarker in the Future
    Murdani Abdullah, Ninik Sukartini, Saskia Aziza Nursyirwan, Rabbinu Rangga Pribadi, Hasan Maulahela, Amanda Pitarini Utari, Virly Nanda Muzellina, Agustinus Wiraatmadja, Kaka Renaldi
    Digestion.2021; 102(6): 823.     CrossRef
  • The effect of periodontal bacteria infection on incidence and prognosis of cancer
    Li Xiao, Qianyu Zhang, Yanshuang Peng, Daqing Wang, Ying Liu
    Medicine.2020; 99(15): e19698.     CrossRef
  • The impact of the gut microbiota on prognosis after surgery for colorectal cancer – a systematic review and meta‐analysis
    Emilie Palmgren Colov, Thea Helene Degett, Hans Raskov, Ismail Gögenur
    APMIS.2020; 128(2): 162.     CrossRef
  • Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut
    Khalid El Bairi, Rachid Jabi, Dario Trapani, Hanae Boutallaka, Bouchra Ouled Amar Bencheikh, Mohammed Bouziane, Mariam Amrani, Said Afqir, Adil Maleb
    Expert Review of Clinical Pharmacology.2020; 13(4): 403.     CrossRef
  • Predictive values of colon microbiota in the treatment response to colorectal cancer
    Jorge Galan-Ros, Verónica Ramos-Arenas, Pablo Conesa-Zamora
    Pharmacogenomics.2020; 21(14): 1045.     CrossRef
  • The gut microbiome and potential implications for early-onset colorectal cancer
    Reetu Mukherji, Benjamin A Weinberg
    Colorectal Cancer.2020;[Epub]     CrossRef
  • Fusobacterium nucleatum in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysis
    Christian Gethings-Behncke, Helen G. Coleman, Haydee W.T. Jordao, Daniel B. Longley, Nyree Crawford, Liam J. Murray, Andrew T. Kunzmann
    Cancer Epidemiology, Biomarkers & Prevention.2020; 29(3): 539.     CrossRef
  • CpG Island Methylation in Sessile Serrated Adenoma/Polyp of the Colorectum: Implications for Differential Diagnosis of Molecularly High-Risk Lesions among Non-dysplastic Sessile Serrated Adenomas/Polyps
    Ji Ae Lee, Hye Eun Park, Seung-Yeon Yoo, Seorin Jeong, Nam-Yun Cho, Gyeong Hoon Kang, Jung Ho Kim
    Journal of Pathology and Translational Medicine.2019; 53(4): 225.     CrossRef
  • Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients
    Andrew T. Kunzmann, Marcela Alcântara Proença, Haydee WT Jordao, Katerina Jiraskova, Michaela Schneiderova, Miroslav Levy, Václav Liska, Tomas Buchler, Ludmila Vodickova, Veronika Vymetalkova, Ana Elizabete Silva, Pavel Vodicka, David J. Hughes
    European Journal of Clinical Microbiology & Infectious Diseases.2019; 38(10): 1891.     CrossRef
  • Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer
    Sally Temraz, Farah Nassar, Rihab Nasr, Maya Charafeddine, Deborah Mukherji, Ali Shamseddine
    International Journal of Molecular Sciences.2019; 20(17): 4155.     CrossRef
  • The Four Horsemen in Colon Cancer
    Marco Antonio Hernández-Luna, Sergio López-Briones, Rosendo Luria-Pérez
    Journal of Oncology.2019; 2019: 1.     CrossRef
  • The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management
    Chun‐Hui Sun, Bin‐Bin Li, Bo Wang, Jing Zhao, Xiao‐Ying Zhang, Ting‐Ting Li, Wen‐Bing Li, Di Tang, Miao‐Juan Qiu, Xin‐Cheng Wang, Cheng‐Ming Zhu, Zhi‐Rong Qian
    Chronic Diseases and Translational Medicine.2019; 5(3): 178.     CrossRef

JPTM : Journal of Pathology and Translational Medicine